Cite Filings / LENZ / 0000950170-25-089455

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

LENZ Therapeutics, Inc. Filed 2025-06-24 Acc 0000950170-25-089455

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-07-14 SCHEDULE 13D/A Beneficial Ownership Report
2025-07-01 4 10% owner sold 200,000 shares at $30.47 ($6,093,000)
2025-06-24 SCHEDULE 13D/A Beneficial Ownership Report
2025-06-20 4 10% owner sold 334,801 shares at an average $30.19 ($10,107,818)
2025-06-12 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…